Intervention to Reduce Dietary Sodium in Hemodialysis
Intervention to Reduce Dietary Sodium in Hemodialysis
批准号:
8101887
负责人:
Mary A Sevick
金额:
$44.94万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2012-12-31
关键词:
AdherenceAgingAttentionBehavior TherapyBehavioralBlood PressureCardiovascular DiseasesCause of DeathCessation of lifeComplexComputer softwareControl GroupsDataDevelopmentDialysis procedureDietDiet RecordsDietary InterventionDietary SodiumDietary intakeEducationEffectivenessEnd stage renal failureFoodHealthHemodialysisHypertensionIntakeInterceptInterventionLeft Ventricular HypertrophyLifeLinear RegressionsLiquid substanceMaintenanceMeasuresMethodsModelingMonitorNatureNon-Insulin-Dependent Diabetes MellitusNutritionalObesityParticipantPatient Self-ReportPatientsPatternPersonal Digital AssistantPersuasive CommunicationPhysiologicalPopulationPrevalencePulse PressureQualitative MethodsQuality of lifeRandomizedRandomized Clinical TrialsRegimenResearchResearch PersonnelSelf EfficacySelf ManagementSodiumSymptomsTaste PerceptionTechnologyTestingWeight GainWorkbasecommon treatmentcomputerizedexperienceextracellulargroup interventionhealth related quality of lifenutritionpatient populationpressurepreventsocial cognitive theorystandard care
中文摘要
描述(由申请人提供):心血管疾病是血液透析(HD)患者死亡的最常见原因。大多数HD患者有左心室肥厚(LVH),这是该人群死亡的重要预测因子。LVH与细胞外体积扩张和高血压有关,这两种情况都可以通过限制饮食中的钠来调节。然而,众所周知,饮食改变很难实现和维持。控制饮食中的钠对于HD来说尤其困难,因为许多食物天然含钠量很高,而且大多数预制/预包装食品都添加了大量的钠,以提高口感和延长保质期。有效减少HD患者膳食钠摄入量的行为方法研究非常有限。本研究的目的是在一项200名HD患者的随机临床试验中,测试行为干预与基于pda的饮食自我监测相结合,以增强对饮食钠限制的依从性。具体而言,研究人员将:(a)评估干预对平均每日透析期体重增加(IDWGA)的影响。(b)检查干预措施对自我报告的饮食钠摄入量的影响。本研究假设与对照组相比,干预组将:(1)在4个月的干预期内,IDWGA有统计学意义上的显著下降,(2)膳食钠摄入量有更大的下降。其次,研究人员将探讨干预对以下方面的影响:(a)透析前脉压和平均动脉血压,(b)血液透析饮食自我效能,以及(c)透析中和透析后症状和一般健康相关生活质量。此外,研究人员将通过使用定性方法描述HD饮食方案的障碍/促进因素以及患者对干预的体验。干预是基于社会认知理论。干预过程中的自我监测采用基于pda的饮食记录,使用BalanceLog软件。随机分配到注意力控制组的参与者将接受计算机化的饮食教育。在4个月的研究期结束后,注意力控制参与者将被提供一个简短的干预版本。将使用随机截距线性回归模型检查IDWGA、脉压和平均动脉压的差异。自我报告的饮食钠、自我效能、症状和生活质量将在基线、6周和4个月时进行评估,并使用GEE重复测量模型检查差异。将对叙事数据进行定性分析。公共卫生相关性:终末期肾病(ESRD)的患病率呈指数级增长,主要是由于2型糖尿病、肥胖和高血压患者数量的增加以及人口老龄化。ESRD最常见的治疗方法是血液透析(HD),该方案需要严格限制饮食中的钠含量,以防止液体容量过载。在这项研究中,研究人员将评估一种行为干预的有效性,这种干预包括基于技术的饮食自我监测,以帮助HD患者限制饮食中的钠摄入量。
英文摘要
DESCRIPTION (provided by applicant): Cardiovascular disease is the single most common cause of death in hemodialysis (HD) patients. Most HD patients have left ventricular hypertrophy (LVH), a significant predictor of death in this population. LVH is related to extra cellular volume expansion and hypertension, both of which are amenable to dietary sodium restriction. However, dietary change is widely known to be difficult to achieve and sustain. Controlling dietary sodium is particularly difficult for HD because many foods are naturally high in sodium, and most prepared/prepackaged foods have significant amounts of sodium added to enhance taste and shelf-life. Research on behavioral methods that are effective in reducing dietary sodium intake in HD is very limited. The purpose of this study is to test, in a randomized clinical trial of 200 HD patients, a behavioral intervention, paired with PDA-based dietary self-monitoring, to enhance adherence to dietary sodium restrictions. Specifically the investigators will: (a) Assess the impact of the intervention on average daily interdialytic weight gains (IDWGA). (b) Examine the impact of the intervention on self-reported dietary sodium intake. The study hypotheses are that compared to the control group, the intervention group will: (1) demonstrate a statistically significant decline in IDWGA over the 4-month intervention period, and (2) experience a greater decline in dietary sodium intake. Secondarily, the investigators will explore the impact of the intervention on: (a) pre-dialysis pulse pressure and mean arterial blood pressure, (b) hemodialysis dietary self-efficacy, and (c) intradialytic and postdialytic symptoms and general health-related quality of life. In addition, the investigators will characterize the barriers/facilitators to adherence to the HD dietary regimen and patient experience of the intervention through the use of qualitative methods. The intervention is based on Social Cognitive Theory. Self-monitoring within the context of the intervention is operationalized as PDA-based dietary recording using BalanceLog software. Participants randomized to the attention control will receive computerized dietary education. Attention control participants will be offered an abbreviated version of the intervention after the 4-month study period concludes. Differences in IDWGA, pulse pressure, and mean arterial pressure will be examined using a random intercept linear regression modeling. Self-reported dietary sodium, self-efficacy, symptoms, and quality of life will be assessed at baseline, 6 weeks, and 4 month and differences will be examined using repeated measures modeling using GEE. Qualitative analysis of narrative data will be performed. PUBLIC HEALTH RELEVANCE: The prevalence of end-stage renal disease (ESRD) is growing exponentially, largely due to the growing number of people with type 2 diabetes, obesity, and hypertension, and the aging of the population. The most common treatment approach for ESRD is hemodialysis (HD), a regimen which requires strict dietary sodium limitations to prevent fluid volume overload. With this study the investigators will evaluate the effectiveness of a behavioral intervention that involves technology- based dietary self-monitoring, for helping those on HD limit their dietary sodium intake.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1097/tin.0000000000000096
发表时间:
2017-04
期刊:
Topics in clinical nutrition
影响因子:
0.5
作者:
[]
通讯作者:
DOI:
10.1097/tin.0b013e3181faba4c
发表时间:
2011-01
期刊:
Topics in clinical nutrition
影响因子:
0.5
作者:
[Stark S, Snetselaar L, Hall B, Stone RA, Kim S, Piraino B, Sevick MA]
通讯作者:
Sevick MA
Behavioral Management of Phosphorus in Hemodialysis
-
批准号:9334846
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2016
-
负责人:Mary A Sevick
-
依托单位:
Lifestyle Management of CKD in Obese Diabetic Patients
-
批准号:8818276
-
项目类别:
-
资助金额:$75.75万
-
财政年份:2014
-
负责人:Mary A Sevick
-
依托单位:
Lifestyle Management of CKD in Obese Diabetic Patients
-
批准号:9323387
-
项目类别:
-
资助金额:$72.4万
-
财政年份:2014
-
负责人:Mary A Sevick
-
依托单位:
Lifestyle Management of CKD in Obese Diabetic Patients
-
批准号:8930137
-
项目类别:
-
资助金额:$73.94万
-
财政年份:2014
-
负责人:Mary A Sevick
-
依托单位:
Program to improve care in complex chronic disease
-
批准号:8327697
-
项目类别:
-
资助金额:$13.38万
-
财政年份:2011
-
负责人:Mary A Sevick
-
依托单位:
Program to Improve Care in Complex Chronic Disease
-
批准号:8731161
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2011
-
负责人:Mary A Sevick
-
依托单位:
Program to improve care in complex chronic disease
-
批准号:8190211
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2011
-
负责人:Mary A Sevick
-
依托单位:
Program to Improve Care in Complex Chronic Disease
-
批准号:8736010
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2011
-
负责人:Mary A Sevick
-
依托单位:
Program to Improve Care in Complex Chronic Disease
-
批准号:8925924
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2011
-
负责人:Mary A Sevick
-
依托单位:
Intervention to Reduce Dietary Sodium in Hemodialysis
-
批准号:7874682
-
项目类别:
-
资助金额:$62.15万
-
财政年份:2008
-
负责人:Mary A Sevick
-
依托单位:
Intervention to Reduce Dietary Sodium in Hemodialysis
-
批准号:7516503
-
项目类别:
-
资助金额:$61.41万
-
财政年份:2008
-
负责人:Mary A Sevick
-
依托单位:
Intervention to Reduce Dietary Sodium in Hemodialysis
-
批准号:7690910
-
项目类别:
-
资助金额:$61.55万
-
财政年份:2008
-
负责人:Mary A Sevick
-
依托单位:
Dietary Adherence Enhancement in Peritoneal Dialysis
-
批准号:7345650
-
项目类别:
-
资助金额:$14.42万
-
财政年份:2006
-
负责人:Mary A Sevick
-
依托单位:
Dietary Adherence Enhancement in Peritoneal Dialysis
-
批准号:7048054
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2006
-
负责人:Mary A Sevick
-
依托单位:
ENHANCING ADHERENCE TO DIABETES SELF-MANAGMENT: THE ENHANCE STUDY
-
批准号:7201142
-
项目类别:
-
资助金额:$2.8万
-
财政年份:2005
-
负责人:Mary A Sevick
-
依托单位:
Enhancing Adherence in Type 2 Diabetics
-
批准号:6890998
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2004
-
负责人:Mary A Sevick
-
依托单位:
Dietary Adherence Intervention in Pts Recg Hemodialysis
-
批准号:6974701
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2004
-
负责人:Mary A Sevick
-
依托单位:
Enhancing Adherence in Type 2 Diabetics
-
批准号:6711396
-
项目类别:
-
资助金额:$40.55万
-
财政年份:2004
-
负责人:Mary A Sevick
-
依托单位:
Enhancing Adherence in Type 2 Diabetics
-
批准号:7014579
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2004
-
负责人:Mary A Sevick
-
依托单位:
Enhancing Adherence in Type 2 Diabetics
-
批准号:7172288
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2004
-
负责人:Mary A Sevick
-
依托单位:
海外基金